1. Executive Summary
1.1. Global Facial Injectable Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Facial Injectable Market Outlook, 2018 - 2031
3.1. Global Facial Injectable Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Botulinum Toxin
3.1.1.1.1. Toxin A
3.1.1.1.2. Toxin B
3.1.1.2. Dermal Fillers
3.1.1.2.1. Hyaluronic Acid
3.1.1.2.2. Poly-L-Lactic Acid
3.1.1.2.3. Calcium Hydroxyapatite
3.1.1.2.4. Poly Methyl methacrylate
3.2. Global Facial Injectable Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Aesthetic Restoration
3.2.1.2. Dentistry
3.2.1.3. Reconstructive Surgery
3.3. Global Facial Injectable Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Hospitals
3.3.1.2. Specialty Clinics
3.3.1.3. Spa & Beauty Clinic
3.4. Global Facial Injectable Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Facial Injectable Market Outlook, 2018 - 2031
4.1. North America Facial Injectable Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Botulinum Toxin
4.1.1.1.1. Toxin A
4.1.1.1.2. Toxin B
4.1.1.2. Dermal Fillers
4.1.1.2.1. Hyaluronic Acid
4.1.1.2.2. Poly-L-Lactic Acid
4.1.1.2.3. Calcium Hydroxyapatite
4.1.1.2.4. Poly Methyl methacrylate
4.2. North America Facial Injectable Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Aesthetic Restoration
4.2.1.2. Dentistry
4.2.1.3. Reconstructive Surgery
4.3. North America Facial Injectable Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Hospitals
4.3.1.2. Specialty Clinics
4.3.1.3. Spa & Beauty Clinic
4.4. North America Facial Injectable Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. U.S. Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
4.4.1.2. U.S. Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
4.4.1.3. U.S. Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
4.4.1.4. Canada Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
4.4.1.5. Canada Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
4.4.1.6. Canada Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Facial Injectable Market Outlook, 2018 - 2031
5.1. Europe Facial Injectable Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Botulinum Toxin
5.1.1.1.1. Toxin A
5.1.1.1.2. Toxin B
5.1.1.2. Dermal Fillers
5.1.1.2.1. Hyaluronic Acid
5.1.1.2.2. Poly-L-Lactic Acid
5.1.1.2.3. Calcium Hydroxyapatite
5.1.1.2.4. Poly Methyl methacrylate
5.2. Europe Facial Injectable Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Aesthetic Restoration
5.2.1.2. Dentistry
5.2.1.3. Reconstructive Surgery
5.3. Europe Facial Injectable Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Hospitals
5.3.1.2. Specialty Clinics
5.3.1.3. Spa & Beauty Clinic
5.4. Europe Facial Injectable Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Germany Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
5.4.1.2. Germany Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
5.4.1.3. Germany Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
5.4.1.4. U.K. Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
5.4.1.5. U.K. Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
5.4.1.6. U.K. Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
5.4.1.7. France Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
5.4.1.8. France Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
5.4.1.9. France Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
5.4.1.10. Italy Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
5.4.1.11. Italy Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
5.4.1.12. Italy Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
5.4.1.13. Turkey Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
5.4.1.14. Turkey Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
5.4.1.15. Turkey Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
5.4.1.16. Russia Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
5.4.1.17. Russia Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
5.4.1.18. Russia Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
5.4.1.19. Rest of Europe Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
5.4.1.20. Rest of Europe Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
5.4.1.21. Rest of Europe Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Facial Injectable Market Outlook, 2018 - 2031
6.1. Asia Pacific Facial Injectable Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Botulinum Toxin
6.1.1.1.1. Toxin A
6.1.1.1.2. Toxin B
6.1.1.2. Dermal Fillers
6.1.1.2.1. Hyaluronic Acid
6.1.1.2.2. Poly-L-Lactic Acid
6.1.1.2.3. Calcium Hydroxyapatite
6.1.1.2.4. Poly Methyl methacrylate
6.2. Asia Pacific Facial Injectable Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Aesthetic Restoration
6.2.1.2. Dentistry
6.2.1.3. Reconstructive Surgery
6.3. Asia Pacific Facial Injectable Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Hospitals
6.3.1.2. Specialty Clinics
6.3.1.3. Spa & Beauty Clinic
6.4. Asia Pacific Facial Injectable Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. China Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
6.4.1.2. China Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
6.4.1.3. China Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
6.4.1.4. Japan Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
6.4.1.5. Japan Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
6.4.1.6. Japan Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
6.4.1.7. South Korea Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
6.4.1.8. South Korea Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
6.4.1.9. South Korea Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
6.4.1.10. India Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
6.4.1.11. India Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
6.4.1.12. India Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
6.4.1.13. Southeast Asia Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
6.4.1.14. Southeast Asia Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
6.4.1.15. Southeast Asia Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
6.4.1.16. Rest of Asia Pacific Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
6.4.1.17. Rest of Asia Pacific Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
6.4.1.18. Rest of Asia Pacific Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Facial Injectable Market Outlook, 2018 - 2031
7.1. Latin America Facial Injectable Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Botulinum Toxin
7.1.1.1.1. Toxin A
7.1.1.1.2. Toxin B
7.1.1.2. Dermal Fillers
7.1.1.2.1. Hyaluronic Acid
7.1.1.2.2. Poly-L-Lactic Acid
7.1.1.2.3. Calcium Hydroxyapatite
7.1.1.2.4. Poly Methyl methacrylate
7.2. Latin America Facial Injectable Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Aesthetic Restoration
7.2.1.2. Dentistry
7.2.1.3. Reconstructive Surgery
7.3. Latin America Facial Injectable Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Hospitals
7.3.1.2. Specialty Clinics
7.3.1.3. Spa & Beauty Clinic
7.4. Latin America Facial Injectable Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Brazil Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
7.4.1.2. Brazil Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
7.4.1.3. Brazil Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
7.4.1.4. Mexico Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
7.4.1.5. Mexico Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
7.4.1.6. Mexico Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
7.4.1.7. Argentina Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
7.4.1.8. Argentina Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
7.4.1.9. Argentina Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
7.4.1.10. Rest of Latin America Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
7.4.1.11. Rest of Latin America Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
7.4.1.12. Rest of Latin America Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Facial Injectable Market Outlook, 2018 - 2031
8.1. Middle East & Africa Facial Injectable Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Botulinum Toxin
8.1.1.1.1. Toxin A
8.1.1.1.2. Toxin B
8.1.1.2. Dermal Fillers
8.1.1.2.1. Hyaluronic Acid
8.1.1.2.2. Poly-L-Lactic Acid
8.1.1.2.3. Calcium Hydroxyapatite
8.1.1.2.4. Poly Methyl methacrylate
8.2. Middle East & Africa Facial Injectable Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Aesthetic Restoration
8.2.1.2. Dentistry
8.2.1.3. Reconstructive Surgery
8.3. Middle East & Africa Facial Injectable Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Hospitals
8.3.1.2. Specialty Clinics
8.3.1.3. Spa & Beauty Clinic
8.4. Middle East & Africa Facial Injectable Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. GCC Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
8.4.1.2. GCC Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
8.4.1.3. GCC Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
8.4.1.4. South Africa Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
8.4.1.5. South Africa Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
8.4.1.6. South Africa Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
8.4.1.7. Egypt Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
8.4.1.8. Egypt Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
8.4.1.9. Egypt Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
8.4.1.10. Nigeria Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
8.4.1.11. Nigeria Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
8.4.1.12. Nigeria Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
8.4.1.13. Rest of Middle East & Africa Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
8.4.1.14. Rest of Middle East & Africa Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
8.4.1.15. Rest of Middle East & Africa Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Product Type vs End User Heatmap
9.2. Manufacturer vs End User Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Nestle Skin Health
9.5.1.1. Company Overview
9.5.1.2. Product Type Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Sinclair Pharma
9.5.2.1. Company Overview
9.5.2.2. Product Type Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Zimmer Biomet
9.5.3.1. Company Overview
9.5.3.2. Product Type Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Anika Therapeutics, Inc.
9.5.4.1. Company Overview
9.5.4.2. Product Type Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Merz Pharma
9.5.5.1. Company Overview
9.5.5.2. Product Type Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Ipsen Pharma
9.5.6.1. Company Overview
9.5.6.2. Product Type Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Teoxane Laboratories
9.5.7.1. Company Overview
9.5.7.2. Product Type Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Prollenium Medical Technologies
9.5.8.1. Company Overview
9.5.8.2. Product Type Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Suneva Medical, Inc.
9.5.9.1. Company Overview
9.5.9.2. Product Type Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Allergan
9.5.10.1. Company Overview
9.5.10.2. Product Type Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations